Hepatocyte transplantation: state of the art and strategies for overcoming existing hurdles.

Sung W. Lee, Xia Wang, Namita Roy Chowdhury, Jayanta Roy-Chowdhury

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Over three decades of research in experimental animals and several clinical trials have brought us to the threshold of hepatocyte transplantation for the treatment of acute and chronic liver failure, and inherited metabolic disorders. However, more extensive clinical studies and routine clinical application are hampered by the shortage of good quality of donor cells. To overcome these hurdles, current research has focused on the search for alternatives to adult primary hepatocytes, such as liver cell progenitors, fetal hepatoblasts, embryonic, bone marrow or umbilical cord blood stem cells and conditionally immortalized hepatocytes. Cross-species hepatocyte transplantation is also being explored. It is hoped that ongoing research will permit the application of hepatocyte transplantation to the treatment of a wide array of liver diseases.

Original languageEnglish (US)
Pages (from-to)48-53
Number of pages6
JournalAnnals of hepatology : official journal of the Mexican Association of Hepatology
Volume3
Issue number2
StatePublished - 2004

Fingerprint

Hepatocytes
Transplantation
Stem Cells
Research
End Stage Liver Disease
Acute Liver Failure
Fetal Blood
Liver Diseases
Blood Cells
Bone Marrow
Clinical Trials
Liver

Cite this

@article{b2762de4e2e34ee9a374c22ae6733885,
title = "Hepatocyte transplantation: state of the art and strategies for overcoming existing hurdles.",
abstract = "Over three decades of research in experimental animals and several clinical trials have brought us to the threshold of hepatocyte transplantation for the treatment of acute and chronic liver failure, and inherited metabolic disorders. However, more extensive clinical studies and routine clinical application are hampered by the shortage of good quality of donor cells. To overcome these hurdles, current research has focused on the search for alternatives to adult primary hepatocytes, such as liver cell progenitors, fetal hepatoblasts, embryonic, bone marrow or umbilical cord blood stem cells and conditionally immortalized hepatocytes. Cross-species hepatocyte transplantation is also being explored. It is hoped that ongoing research will permit the application of hepatocyte transplantation to the treatment of a wide array of liver diseases.",
author = "Lee, {Sung W.} and Xia Wang and Chowdhury, {Namita Roy} and Jayanta Roy-Chowdhury",
year = "2004",
language = "English (US)",
volume = "3",
pages = "48--53",
journal = "Annals of Hepatology",
issn = "1665-2681",
publisher = "Mexican Association of Hepatology",
number = "2",

}

TY - JOUR

T1 - Hepatocyte transplantation

T2 - state of the art and strategies for overcoming existing hurdles.

AU - Lee, Sung W.

AU - Wang, Xia

AU - Chowdhury, Namita Roy

AU - Roy-Chowdhury, Jayanta

PY - 2004

Y1 - 2004

N2 - Over three decades of research in experimental animals and several clinical trials have brought us to the threshold of hepatocyte transplantation for the treatment of acute and chronic liver failure, and inherited metabolic disorders. However, more extensive clinical studies and routine clinical application are hampered by the shortage of good quality of donor cells. To overcome these hurdles, current research has focused on the search for alternatives to adult primary hepatocytes, such as liver cell progenitors, fetal hepatoblasts, embryonic, bone marrow or umbilical cord blood stem cells and conditionally immortalized hepatocytes. Cross-species hepatocyte transplantation is also being explored. It is hoped that ongoing research will permit the application of hepatocyte transplantation to the treatment of a wide array of liver diseases.

AB - Over three decades of research in experimental animals and several clinical trials have brought us to the threshold of hepatocyte transplantation for the treatment of acute and chronic liver failure, and inherited metabolic disorders. However, more extensive clinical studies and routine clinical application are hampered by the shortage of good quality of donor cells. To overcome these hurdles, current research has focused on the search for alternatives to adult primary hepatocytes, such as liver cell progenitors, fetal hepatoblasts, embryonic, bone marrow or umbilical cord blood stem cells and conditionally immortalized hepatocytes. Cross-species hepatocyte transplantation is also being explored. It is hoped that ongoing research will permit the application of hepatocyte transplantation to the treatment of a wide array of liver diseases.

UR - http://www.scopus.com/inward/record.url?scp=4043048744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4043048744&partnerID=8YFLogxK

M3 - Article

C2 - 15257246

AN - SCOPUS:4043048744

VL - 3

SP - 48

EP - 53

JO - Annals of Hepatology

JF - Annals of Hepatology

SN - 1665-2681

IS - 2

ER -